Selected Publications

Shah T., Shah H., Zhang Z., Fanaroff A., Nathan A., Parise H., Lutz J., Sugeng L., Bellumkonda L., Redfors B., Omerovic E., Petrie M., Vora A., Fiorilli P., Kobayashi T., Ahmad Y., Forrest J., Giri J., Herrmann H., Lansky A.: TCT-187 Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis. Journal of the American College of Cardiology 2024 84:18 Supplement (B10-) 84(18): 738-748, Mar 2025.

Fanaroff AC, Huang Q, Norton LA, Kellum WE, Eichelberger D, Wood JC, Bricker Z, Dooley Wood AG, Kemmer G, Smith JI, Adusumalli S, Putt ME, Volpp KG. : Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation: Two Pragmatic Cluster-Randomized Clinical Trials. JAMA Cardiol 26: e250244, Mar 2025.

Sanyi A, Byiringiro S, Dabiri S, Jacobson M, Boyd A, Ogunniyi MO, Morris AA, Kohn R, Dickert NW, Lane-Fall MB, Lewis EF, Halpern SD, Fanaroff AC. : Measuring representativeness in clinical trials. Circulation 151(5): 318-330, Feb 2025.

Fanaroff AC, Vora AN, Wojdyla DM, Mehran R, Granger CB, Goodman SG, Aronson R, Windecker S, Alexander JH, Lopes RD. : Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUS. Am Heart J 280: 60-69, Feb 2025.

Kohn R, Sheu D, Britez Ferrante E, Lieberman A, Maitra MR, Drakes J, Stephens-Shields AJ, Okoh AK, Fanaroff AC, Morris AA, Ogunniyi MO, Dickert NW, Halpern SD, Lane-Fall MB: Who Are We Missing? Reporting of Ethnicity, Race, and Sex-Specific Populations in Clinical Trials. J Am Heart Assoc 14(1): e037375, Jan 2025.

Shah T, Fanaroff AC. : State-of-the-Art Review: Percutaneous Coronary Intervention in Acute Coronary Syndrome. Curr Treat Options Cardio Med. 27: 13, Jan 2025.

Reddy KP, Mehta S, Eberly LA, Khatana SAM, Wang GJ, Damrauer SM, Fanaroff AC, Groeneveld PW, Giri J, Nathan AS.: Delayed or forgone medical care associated with increased resource utilization and health care expenditures among patients with peripheral artery disease in the United States. J Vasc Surg. 10: S0741-5214(25)00022-9, Jan 2025.

Schwartz AW, Shah Y, Huang H, Nathan A, Fanaroff AC, Giri JS, Parikh SA, Lansky AJ, Shah T. : Comparison of Endovascular Interventions for the Treatment of Superficial Femoral Artery Disease: A Network Meta-analysis. J Soc Cardiovasc Angiogr Interv. 4(1): 102432, Jan 2025.

Ramadan OI, Yang L, Shultz K, Genovese E, Damrauer SM, Wang GJ, Secemsky EA, Treat-Jacobson DJ, Womeodu RJ, Fakorede FA, Nathan AS, Eberly LA, Julien HM, Kobayashi TJ, Groeneveld PW, Giri J, Fanaroff AC. : Racial, socioeconomic, and geographic disparities in pre-amputation vascular care for patients with chronic limb-threatening ischemia. Circ Cardiovasc Qual Outcomes 18(1): e010931, Jan 2025.

Mehta M, Fanaroff AC, Rhodes CM, Xiong A, Snider CK, Fagen EM, Harhay MO, Mehrabyan N, Peifer MK, Volpp KG, Delgado MK: Changing default prescription length to reduce barriers to statin adherence: Impact on equity. JAMA Intern Med 2025.